Company / Operating Margin
Fortress Biotech, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-191.4%
FY2025
5-year range
-274.1% / -168.4%
FY2021-FY2025
Trend
-13.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 10 years, ranging from -5855.3% in FY2017 to -168.4% in FY2024.
Based on SEC 10-K filings.
-191.4% in FY2025 with a 5-year CAGR of +111.2%.
Improved from -268.8% to -191.4% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +82.7pp
- 5-Year Change
- +111.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 13.6% year-over-year.
- Peak operating margin was recorded in FY2024.
- Lowest operating margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -191.4% | -13.6% |
| FY2024 | -168.4% | +37.3% |
| FY2023 | -268.8% | +1.9% |
| FY2022 | -274.1% | -32.6% |
| FY2021 | -206.7% | +31.7% |
| FY2020 | -302.5% | +32.2% |
| FY2019 | -446.4% | +14.3% |
| FY2018 | -520.7% | +91.1% |
| FY2017 | -5855.3% | -144.7% |
| FY2016 | -2393.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026